| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |